MarketWatch Rainier will randomize approximately 130 patients to receive either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy. The primary endpoint of the trial will be overall survival, with additional analyses to evaluate progression ...
pharmabiz.com Rainier will randomize approximately 130 patients to receive either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy. The primary ...
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
Marketwire (press release) Celgene's treatment includes gemcitabine (Gemzar) in combination with their drug Abraxane, a nanoparticle albumin-bound formulation of paclitaxel (Taxol). Continue reading this article at www.stockhousegroup.com/features. About Stock House Group ... and more »
DailyFinance An open-label Phase I trial of ruxolitinib in combination with chemotherapy in patients with advanced solid tumors was initiated in April 2013. The primary endpoint is identification of the maximum tolerated dose of ruxolitinib in combination with ... and more »
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
CTV News The problem was caught March 20 when a pharmacy assistant at the Peterborough Regional Health Centre doubled-checked the label of a bag containing a mixture of ...
Marketwire (press release) TH-302 is currently under evaluation in two Phase 3 trials: one in combination with doxorubicin versus doxorubicin alone in patients with soft tissue sarcoma (STS), and the other in combination with gemcitabine versus gemcitabine and placebo in ... and more »
MarketWatch Rainier will randomize approximately 130 patients to receive either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy. The primary endpoint of the trial will be overall survival, with additional analyses to evaluate progression ...
Canada NewsWire (press release) Rainier will randomize approximately 130 patients to receive either OGX-427 or placebo in combination with ABRAXANE and gemcitabine the...
